HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA cosmetics hotline

This article was originally published in The Rose Sheet

Executive Summary

FDA cosmetics hotline: Consumer Cosmetics Adverse Reaction hotline may be up and running by "early summer," FDA says. The agency is in the process of reworking the design of the toll-free line to ameliorate industry concerns over the potential of the reporting system to overlap with other FDA programs and the agency's ability to deal with false calls ("The Rose Sheet" Nov. 28, p. 2). The hotline initially was scheduled to commence in December...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel